Private Label Tranexamic Acid Body Wash Manufacturer Low MOQ

Most private label cosmetic manufacturers who work with tranexamic acid body wash accept MOQs between 200 and 1,000 units, depending on whether you choose a stock base or a fully custom formula. At the low end — 200 to 500 units — you will almost always be working with a manufacturer's pre-existing surfactant base into which tranexamic acid is blended at your specified concentration. This is the fastest and most affordable path for a first launch. The manufacturer has already validated the base formula, which means you skip the longest part of development. You pay for the active ingredient, filling, and labeling, and your NRE (non-recurring engineering) fee covers any required stability top-up testing. For a semi-custom formula — meaning you adjust the surfactant system, fragrance, co-actives like niacinamide or kojic acid, or texture — MOQs typically start at 500 units. The manufacturer needs to batch a larger volume to justify the reformulation time and additional QC checks. Fully custom formulas, where a cosmetic chemist builds your formula from scratch with a proprietary blend and possibly a unique preservative system, generally require 1,000 units at minimum. Below that, the cost per unit becomes unworkable because batch setup costs don't scale down proportionally. Several factors push MOQs up even if a manufacturer advertises low minimums: (1) if your packaging is custom-molded rather than stock, the packaging supplier often requires 5,000–10,000 units minimum, effectively setting your bottle MOQ far above the fill MOQ; (2) if you require third-party stability testing or a HRIPT (human repeat insult patch test), those testing costs are fixed regardless of run size and raise your effective per-unit cost; (3) if you want your formula registered under EU CPNP or require a full Safety Assessment, those fixed professional fees are amortized over your run. On the AJ Cosmo Labs app, you can filter manufacturers explicitly by MOQ range, so you only engage with suppliers whose floor matches your budget. This alone saves founders weeks of back-and-forth with factories that quietly only want 10,000-unit runs. The practical advice for a first-time founder: start with a stock-base + TXA option at 200–300 units, validate consumer response, then renegotiate a custom formula at 1,000+ units on your second run with real sales data behind you.

The cost to private label a tranexamic acid body wash breaks down into four buckets: formulation and development, raw materials and filling, packaging, and regulatory/testing. Understanding each one stops you from being surprised by invoices. Formulation and development: If you use a stock base with TXA added in, some manufacturers charge no separate development fee — it's included in the per-unit price. For semi-custom or fully custom work, expect a one-time R&D fee of $800–$3,500 depending on complexity and how many revision rounds the cosmetic chemist needs. This fee is usually non-refundable. Raw materials and filling: At 200–500 units, per-unit manufacturing cost typically runs $4.50–$7.00. At 500–1,000 units, $3.50–$5.50. At 1,000–5,000 units, $2.00–$4.00. Tranexamic acid itself is a meaningful cost driver: pharmaceutical-grade TXA at 1% inclusion in a 300 ml body wash adds roughly $0.30–$0.60 per unit at small scale; at 2% inclusion it can reach $0.80–$1.20. Always ask for an itemized Bill of Materials so you can see the TXA line separately. Packaging: Stock HDPE or PET bottles with a pump or flip-cap cost $0.40–$0.90 each at low MOQ. Labels (full-wrap BOPP with gloss or matte laminate) run $0.15–$0.40 each for short-run digital printing. Premium packaging — aluminum tubes, airless pumps, frosted glass — adds $0.80–$2.50 per unit and may carry their own MOQ of 2,000–5,000 units from the component supplier. Regulatory and testing: Accelerated stability testing costs $400–$1,200 for a 3-month study. A Cosmetic Safety Assessment for EU compliance runs $600–$2,000 from a qualified assessor. Challenge testing (ISO 11930) to validate your preservative system is $300–$700. Third-party heavy metals or microbial testing adds $150–$400 per batch. All-in for a first run of 300 units with stock packaging and basic stability documentation, budget $3,500–$6,000 total. For 1,000 units with a custom formula, full stability, EU safety assessment, and custom label — budget $8,000–$15,000. These are realistic ranges, not worst-case scenarios. AJ Cosmo Labs helps you collect multiple quotes from vetted manufacturers in one place so you can compare BOM line-by-line rather than comparing apples to oranges across different quotation formats.

The manufacturing timeline for a private label tranexamic acid body wash from contract signing to product-in-hand typically runs 8–20 weeks. The exact duration depends on whether you're using a stock or custom formula, your packaging choices, and whether you need regulatory documentation for international markets. Weeks 1–2: Onboarding and brief review. You sign an NDA and manufacturing agreement, submit your formulation brief, and the manufacturer confirms TXA sourcing. If they stock cosmetic-grade tranexamic acid, you skip an extra 2–3 week procurement window. If they need to order it — especially pharmaceutical-grade material with a current CoA — add 2–4 weeks. Weeks 2–5: Formula development and lab batch. For a stock base with TXA add-in, the cosmetic chemist may deliver a lab sample within 1–2 weeks. For a semi-custom or fully custom formula, allow 3–5 weeks for development, internal QC, and pH/viscosity confirmation. Weeks 5–7: Sample review. You receive a lab sample (typically 100–250 ml in an unlabeled bottle), test it for texture, lather, scent, and skin feel, and provide feedback. One revision round is usually included; additional rounds cost time (1–2 weeks each) and sometimes money. Weeks 7–12: Stability and challenge testing. Accelerated stability at 40°C/75% RH takes a minimum of 4 weeks to generate a meaningful data point, though most labs run 8–12 weeks for a shelf-life claim. If your timeline is tight, some manufacturers will begin production conditionally while stability runs in parallel — this is a risk you assume explicitly. Weeks 10–14: Bulk production and filling. Once formula is approved, the actual fill and label run for 200–1,000 units takes 1–3 weeks of production time. Longer for larger batches. Weeks 13–16 (or later): QC release, documentation package, and shipping. The manufacturer performs final batch QC, prepares your Certificate of Analysis, and ships finished goods. International freight adds 1–4 weeks depending on origin and mode. The single biggest timeline killer is indecision during the sample review phase. Founders who take 4–6 weeks to respond to a sample — usually because they are shopping it to focus groups — can double their entire timeline. Have your evaluation criteria written down before the sample arrives.

Tranexamic acid is considered safe for cosmetic use in a body wash format when used at concentrations up to approximately 3% in rinse-off products, based on the available safety data and the assessments of major regulatory bodies. There is no global ban or specific restriction on TXA in cosmetics as of 2024. In the United States, the FDA does not have a specific approved list for cosmetic ingredients the way it does for food additives or drug actives. Cosmetic safety is the responsibility of the manufacturer and brand owner under the Federal Food, Drug, and Cosmetic Act (FD&C Act). Tranexamic acid is used at cosmetic concentrations and, in a rinse-off format, does not penetrate skin sufficiently to trigger drug-classification concerns. It is not on the FDA's list of prohibited or restricted cosmetic ingredients. The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) tightened safety substantiation requirements for cosmetic brands, so your manufacturer should provide you with a safety substantiation package regardless. In the European Union, cosmetic ingredients are governed by Regulation (EC) No 1223/2009. Tranexamic acid does not appear in Annex II (prohibited substances) or Annex III (restricted substances) as of the most recent updates, meaning it may be used at cosmetically appropriate concentrations. However, EU law requires a Cosmetic Safety Assessment (Annex I Part B) signed by a qualified cosmetic safety assessor before any product is placed on the EU market. That assessor will evaluate TXA concentration, skin penetration data, and rinse-off exposure in their risk assessment. In Japan, tranexamic acid occupies an unusual dual status: it is approved as a quasi-drug (医薬部外品) brightening active at concentrations up to 2%, meaning products making brightening claims with TXA may be classified as quasi-drugs and require pre-market approval. If you intend to sell in Japan, consult a regulatory specialist before launch. In South Korea, TXA is permitted in cosmetics and widely used in K-beauty brightening products. No special restrictions apply for rinse-off formats. For a US-only launch, the practical regulatory steps are: complete INCI labeling, substantiate your claims as cosmetic (not drug) claims, file voluntarily with FDA's VCRP, and retain a safety dossier. For EU or multi-market launches, budget for a qualified safety assessor and CPNP notification. The common first-timer mistake is making drug-adjacent claims like "treats hyperpigmentation" or "clinically proven to eliminate dark spots" — language that can pull a cosmetic body wash into OTC drug territory in the US or trigger regulatory scrutiny in the EU. Stick to cosmetic claim language: "helps visibly even skin tone," "brightening body wash," "reduces the appearance of uneven pigmentation."

A well-formulated tranexamic acid body wash almost always combines TXA with one or more co-actives to amplify brightening results and address multiple steps of the melanogenesis pathway simultaneously. Here are the most commonly used pairings and what each one contributes. Niacinamide (vitamin B3): The most popular co-active with TXA. Used at 2–5% in rinse-off formulas, niacinamide inhibits the transfer of melanosomes from melanocytes to keratinocytes — a different mechanism than TXA's tyrosinase pathway suppression. Together they produce a complementary brightening effect. Niacinamide is inexpensive, well-tolerated, and has a strong consumer recognition factor. It is also stable across the pH range suitable for TXA, making it a natural partner. Alpha-arbutin: A tyrosinase inhibitor with strong clinical backing. Used at 0.5–2% in rinse-off products. More expensive than beta-arbutin but more stable and effective. Pairs well with TXA without pH conflicts. Vitamin C derivatives (ascorbyl glucoside, sodium ascorbyl phosphate): Ascorbic acid itself is difficult to stabilize in a water-based wash, but its stable derivatives work well at 2–3%. They inhibit melanin synthesis and provide antioxidant protection. Note: some vitamin C derivatives can interact with certain surfactants — your cosmetic chemist should run compatibility testing. Kojic acid: A fungal-derived tyrosinase inhibitor used at 0.5–1%. Effective but can cause skin sensitization in some individuals. If included, your safety assessor may want consumer tolerance data. Licorice root extract (glabridin): A natural brightening agent with good consumer appeal. Used at 0.1–0.5%. Stable in acidic wash bases and adds a natural/botanical positioning story. AHA/BHA exfoliants (lactic acid, salicylic acid): Some TXA body washes add low-level exfoliation (lactic acid at 2–5%, or salicylic acid at 0.5–1% in the US where it doesn't tip into OTC drug territory for non-acne claims). Exfoliation accelerates removal of pigmented corneocytes, enhancing visible results. Hyaluronic acid and humectants: At 0.1–0.5%, sodium hyaluronate adds a moisturizing after-feel that counterbalances the stripping sensation some consumers associate with brightening washes. Glycerin at 2–5% is a lower-cost alternative. Fragrance or masking agent: TXA itself is nearly odorless, but the surfactant base may have a detergent note. A light, skin-safe fragrance (or fragrance-free positioning for sensitive skin audiences) is a branding decision your cosmetic chemist and packaging designer should align on early. When briefing manufacturers through AJ Cosmo Labs, list your desired co-actives, their target concentrations, and any claims you want to support — this allows the cosmetic chemist to assess compatibility and quote accurately from the start.

Vetting a private label cosmetic manufacturer before you commit money is one of the highest-leverage activities a new brand founder can do. A poor vetting process leads to delayed launches, failed stability, regulatory non-compliance, or outright fraud. Here is the complete process. Step 1 — Request documentation before any conversation gets serious. Ask for: ISO 22716 GMP certificate (or equivalent), business license, proof of product liability insurance, and a recent third-party audit report if available. A legitimate manufacturer provides these without hesitation. If they stall or offer excuses, walk away. Step 2 — Evaluate their formulation capabilities specifically for tranexamic acid. Ask: do you stock cosmetic-grade tranexamic acid and can you provide a current CoA from your supplier? What pH range do you formulate rinse-off brightening products in? Have you done stability on TXA at 1–2% in a surfactant base before? A cosmetic chemist at a capable facility should answer these confidently. Vague answers — "we can source whatever you need" — suggest they've never actually done it. Step 3 — Request references or case studies. Ask for two or three brands they've manufactured for in a similar category (brightening or active-ingredient body wash). You don't need to contact those brands if the manufacturer can share a redacted BOM or anonymized stability summary as proof of capability. Step 4 — Order a sample of an existing product before committing to custom development. Many reputable manufacturers will sell you a sample of a comparable stock product (not your formula, just something they make) so you can evaluate their manufacturing quality, texture, labeling, and packaging execution. This costs $50–$200 and tells you a lot. Step 5 — Review the manufacturing agreement carefully. Key provisions to check: IP ownership of your formula (you should own it, not them), minimum shelf-life guarantee on delivered product, what happens if a batch fails QC, payment milestones tied to deliverables rather than calendar dates, and exclusivity terms if you want to prevent them from selling the same formula to a competitor. Step 6 — Confirm their capacity matches your growth plan. A micro-manufacturer with a 50-liter kettle is fine for 200-unit runs but cannot scale to 5,000 units without outsourcing to a third party — which reintroduces supply chain risk you didn't vet. Step 7 — Verify their regulatory support capability. Can they supply a full PIF-ready dossier for EU? Do they have experience preparing documentation for MoCRA safety substantiation? Will they list as the Responsible Person for EU notifications if needed? AJ Cosmo Labs pre-screens manufacturers on the platform for GMP documentation and category experience, which compresses steps 1 and 2 significantly. You can open the app, post your TXA body wash brief with your vetting criteria included, and receive responses only from suppliers who match your filters — saving weeks of cold outreach.

Yes, a private label tranexamic acid body wash can be sold on Amazon, Sephora, Target.com, and other major retail and e-commerce channels — but each channel has distinct compliance requirements that your manufacturing setup must support. Amazon: Amazon's Beauty category requires that cosmetics sold through their platform comply with all applicable federal regulations (FD&C Act, MoCRA) and carry correct INCI labeling, net weight, and manufacturer or distributor contact information. As of 2023, Amazon increasingly requests safety documentation for active-ingredient products flagged by their algorithm. For a TXA body wash, be prepared to upload a Certificate of Analysis, your manufacturer's GMP certificate, and possibly a dermatologist safety statement if Amazon requests it during listing review. Amazon also prohibits certain drug claims — review their restricted product policy before writing your listing copy. Average new brand approval time for Beauty on Amazon: 1–4 weeks. Sephora (and Sephora.com): Sephora's brand onboarding process is rigorous. They require full formula disclosure, stability data, safety assessment, and proof of GMP manufacturing. They also evaluate brand positioning, packaging quality, and demand signals (social proof, press coverage, DTC sales history). Most indie brands apply through Sephora's Accelerate program or through a buyer pitch. Lead time from application to shelf: typically 12–24 months. Your manufacturing partner must be able to supply at Sephora's reorder velocity — sometimes 500–1,000 units per SKU per month at full rollout. Ulta Beauty: Similar rigor to Sephora. Ulta has been actively seeking multicultural and skin-tone-inclusive brands, which makes a well-positioned TXA body wash relevant. They require finished product testing including microbial and stability data. Target (Target.com / in-store): Target's beauty buyer process is competitive but accessible for indie brands via their Target Forward accelerator and vendor portal. DTC sales history and strong social proof help. Requirements mirror Sephora in terms of regulatory documentation. DTC (your own website, Shopify): The lowest barrier to entry. You control your claims, your customer data, and your pricing. No third-party compliance review beyond legal requirements. Best channel to launch first, collect reviews, and build the sales history that retailer buyers want to see. The most common mistake is launching on Amazon before having proper compliance documentation, then getting a listing pulled during a peak sales period. Build your safety dossier during manufacturing, not after. AJ Cosmo Labs can connect you with cosmetic regulatory consultants alongside manufacturers so you build both in parallel.